Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Parexel International Corp.

www.parexel.com

Latest From Parexel International Corp.

Real-World Reluctance? Despite Guidance, Drug Developers Wary Of RWE-Based Trials

Biopharma companies are reluctant to rely on real-world evidence trials, but while uncertainty remains about how these novel studies will be accepted, US and other regulators are encouraging drug developers to take a chance – and some have taken on the challenge.

Clinical Trials Research and Development Strategies

Pharma’s Bedtime Horror Stories: Gene Therapy, Digital Revolution, Pricing ‘Fixes’

Regulators, industry executives, and patient advocates are losing sleep due to a host of concerns and anxieties, including the need for evolving regulatory paradigms, patients’ ability to access life-changing medicines, and the pace of digital change.


Gene Therapy Digital Health

Asia Executives On The Move: BMS Names New China GM, New President For Nippon Kayaku

The coming of summer has seen a flurry of executive changes in the Asia Pacific biopharma sector. BMS has named a new China GM amid a fierce immuno-oncology battle, Parexel Japan has a new president, and other personnel changes take place at Nippon Kayaku, Zai Lab and Harbour BioMed.

Appointments China

Cell/Gene Therapy Manufacturing Readiness Urged As A Condition For US Expedited Designation

Requiring that certain chemistry, manufacturing and controls conditions be satisfied before awarding breakthrough or regenerative medicine advanced therapy status would help ensure that the quality side of product development keeps pace with the clinical side, says Parexel's Mo Heidaran, a former CMC reviewer in the FDA’s biologics center.

Regenerative Medicine Gene Therapy
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Parexel International Corp.
  • Senior Management
  • Jamie Macdonald, CEO
    Greg Rush, EVP, CFO
    Peyton Howell, EVP, Chief Commercial & Strategy Officer
    Sy Pretorius, MD, SVP, CSO
    Gadi Saarony, SVP, Clinical Research Services
  • Contact Info
  • Parexel International Corp.
    Phone: (781) 487-9900
    195 West Street
    Waltham, MA 02451
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register